Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients

被引:136
作者
Hawley, Sarah T. [1 ]
Volk, Robert J. [2 ,3 ]
Krishnamurthy, Partha [4 ]
Jibaja-Weiss, Maria [2 ]
Vernon, Sally W. [5 ]
Kneuper, Suzanne [2 ]
机构
[1] Univ Michigan, Div Gen Med, Ann Arbor VA HSR&D, Dept Internal Med, Ann Arbor, MI 48109 USA
[2] Baylor Coll Med, Dept Family & Community Med, Houston, TX 77030 USA
[3] Houston Ctr Educ & Res Therapeut, Houston, TX USA
[4] Univ Houston, CT Bauer Coll Business, Dept Mkt & Enterpreneurship, Houston, TX USA
[5] Univ Texas Houston, Sch Publ Hlth, Div Hlth Promot & Behav Sci, Houston, TX USA
基金
美国医疗保健研究与质量局;
关键词
preferences; colorectal cancer screening; conjoint analysis;
D O I
10.1097/MLR.0b013e31817d932e
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Incorporating patients' preferences into colorectal cancer (CRC) screening recommendations has been identified as a potential mechanism for increasing adherence. This study used conjoint analysis to describe variation in CRC screening preferences among racially/ethnically diverse primary care patients. Methods: We recruited patients ages 50-80 of a large practice-based research network stratified by white, African American, or Hispanic race/ethnicity to complete a preference assessment instrument. Participants were asked to rate 8 hypothetical CRC screening test scenarios comprised of different combinations of 5 attributes and 6 scenarios designed to depict guideline-recommended CRC screening tests (eg, fecal occult blood test, flexible sigmoidoscopy, colonoscopy, and double contrast barium enema) including new technology (eg, virtual colonoscopy, fecal immunochemical test). Responses were used to calculate the overall importance of test attributes, the relative importance of attribute levels, and to identify factors associated with preferences. Results: Two hundred twelve primary care patients were recruited to the study (74 white, 60 African American, 78 Hispanic). Of the guideline-recommended tests, 37% preferred COL, 31% FOBT 15% BE, and 9% SIG. Ratings of new technology tests were 9 significantly (P < 0.05) higher than ratings of guideline-recommended tests. The order of the importance of attributes was: what the test involved (37%), accuracy (19%), frequency (17%), discomfort (15%), and preparation ( 13%). Part-worth utilities for I attribute showed that collecting a stool sample was most preferable and endoscopy without sedation least preferable. Multivariate regression found that race/ethnicity and specific test attributes were independently associated (P < 0.05) with test preferences. Conclusions: Primary care patients have distinct preferences for CRC screening tests that can be linked to test attributes. Racial/ethnic variations in test preferences persist when controlling for attributes. Tailoring screening recommendations to patients' preferences may increase screening adherence.
引用
收藏
页码:S10 / S16
页数:7
相关论文
共 57 条
[1]   Disparities in colon cancer presentation and in-hospital mortality in Maryland: A ten-year review [J].
Ahuja, Nita ;
Chang, David ;
Gearhart, Susan L. .
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) :411-416
[2]  
AMAYAAMAYA M, 2008, SPRINGER PUBLICATION
[3]  
American Cancer Society, COL CANC SCREEN GUID
[4]  
Anderson TW., 2003, INTRO MULTIVARIATE S
[5]  
[Anonymous], 2001, CROSS QUAL CHASM
[6]  
[Anonymous], 2004, Health Affairs, DOI DOI 10.1377/HLTHAFF.VAR.54
[7]   Racial and ethnic disparities in the use of health services - Bias, preference, or poor communication? [J].
Ashton, CM ;
Haidet, P ;
Paterniti, DA ;
Collins, TC ;
Gordon, HS ;
O'Malley, K ;
Petersen, LA ;
Sharf, BF ;
Suarez-Almazor, ME ;
Wray, NP ;
Street, RL .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 (02) :146-152
[8]  
Bowling A, 2001, QUAL HLTH CARE S1, V10, pi2, DOI DOI 10.1136/QHC.0100002
[9]   Racial/ethnic differences in preferences for total knee replacement surgery [J].
Byrne, Margaret M. ;
Souchek, Julianne ;
Richardson, Marsha ;
Suarez-Almazor, Maria .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2006, 59 (10) :1078-1086
[10]  
Byrne MM, 2004, J RHEUMATOL, V31, P1811